Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020-Reference-Cited by-同舟云学术

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020

Published:2023-04-18 Issue:8 Volume:12 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Essa Mohammed¹^ORCID,Ross Joseph S.²³⁴^ORCID,Dhruva Sanket S.⁵^ORCID,Desai Nihar R.⁶^ORCID,Yeh Robert W.⁷^ORCID,Faridi Kamil F.⁶^ORCID

Affiliation:

1. New England Heart and Vascular Institute Catholic Medical Center Manchester NH USA

2. Center for Outcomes Research and Evaluation, Yale New Haven Health System New Haven CT USA

3. Section of General Internal Medicine, Department of Medicine, Yale School of Medicine New Haven CT USA

4. Department of Health Policy and Management, Yale School of Public Health New Haven CT USA

5. Section of Cardiology, Department of Medicine University of California at San Francisco School of Medicine San Francisco CA USA

6. Section of Cardiovascular Medicine, Department of Medicine Yale School of Medicine; Center for Outcomes Research and Evaluation, Yale New Haven Health System New Haven CT USA

7. Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA USA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2. Antithrombotic Therapy for Peripheral Artery Disease

3. Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

4. Medicare & Medicaid Spending by Drug . Centers for Medicare & Medicaid Services. Accessed July 21 2022. https://data.cms.gov/summary‐statistics‐on‐use‐and‐payments/medicare‐medicaid‐spending‐by‐drug.

5. Clinician Cost Measures: Methodology for Incorporation of Rebates in Part D Standardized Amounts . Centers for Medicare & Medicaid Services. Accessed July 30 2022. https://www.cms.gov/files/document/methodology‐incorporation‐rebates‐part‐d‐standardized‐amounts.pdf.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting;European Journal of Human Genetics;2024-02-29